Balance Sheet

v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2023
Dec. 31, 2022
[1]
Current Assets    
Cash and cash equivalents $ 49,900 $ 21,500
Accounts receivable, net of allowance for credit losses of $168,300 390,800 640,500
Inventory 16,400 9,400
Contract assets 17,300 138,700
Prepaid expenses and other current assets 87,100 85,800
Assets held for sale 54,300 217,200
Total Current Assets 615,800 1,113,100
Property and equipment, net 23,900 38,600
Intangible Assets, net 18,600 20,700
Right of use assets 206,500 249,700
Investments 182,200 182,200
Other assets 40,000 40,100
TOTAL ASSETS 1,087,000 1,644,400
Current Liabilities    
Accounts payable 753,900 1,044,700
Accrued liabilities 3,564,000 2,953,800
Contract liabilities 656,800 536,000
Deferred revenue 14,600
Short term notes 4,248,200 3,518,000
Short term notes and accrued interest - related party 194,200 184,000
Convertible notes 1,605,000 1,605,000
Current portion of long term debt and capital lease obligations 504,400 504,300
Current portion of lease liabilities 70,000 63,100
Liabilities held for sale 54,000 85,500
Total Current Liabilities 11,665,100 10,494,400
Lease liabilities net of current portion 164,400 217,400
Long term debt 1,837,200 1,840,600
Total Liabilities 13,666,700 12,552,400
Commitments and contingencies
Stockholders’ deficit    
Preferred stock; $.001 par value; 5,000,000 shares authorized; -0- shares issued
Common stock; $.001 par value; 70,000,000 shares authorized; 65,088,575 shares issued, issuable* and outstanding September 30, 2023  and December 31, 2022 65,100 65,100
Common stock issuable 25,000 25,000
Additional paid-in capital 22,973,800 22,973,800
Stock Subscription receivable (25,000) (25,000)
Accumulated deficit (33,675,300) (32,005,100)
Total stockholders’ deficit (10,636,400) (8,966,200)
Non-controlling interest (1,943,300) (1,941,800)
Total Deficit (12,579,700) (10,908,000)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT $ 1,087,000 $ 1,644,400
[1] Derived from audited information

Source